Valuation: AbbVie Inc.

Market Cap 467B 401B 375B 343B 647B 44,758B 653B 4,435B 1,724B 22,475B 1,755B 1,717B 74,361B P/E 2026 *
33.8x
P/E 2027 * 25x
Enterprise Value 528B 452B 423B 387B 730B 50,550B 738B 5,008B 1,947B 25,383B 1,982B 1,939B 83,984B EV / Sales 2026 *
7.81x
EV / Sales 2027 * 7.06x
Free-Float
95.71%
Yield 2026 *
2.59%
Yield 2027 * 2.72%
1 day-0.17%
1 week+5.67%
Current month+5.41%
1 month+1.99%
3 months+22.63%
6 months+15.79%
Current year+15.77%
1 week 259.55
Extreme 259.55
266.96
1 month 241.2
Extreme 241.2
267.47
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 69 2012-12-31
Date Insider Type Main position Quantity % Market Cap.
8/14/26 Fiscal year

Executive/Senior Manager

98,130 0.0056%
6/30/26 Free

Director

62 0.0000%
6/30/26 Free

Director

134 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.17%+5.67%+25.60%+80.40% 468B
-0.67%+5.39%+75.21%+127.54% 1,119B
+1.04%+4.07%+52.29%+65.39% 651B
-1.38%+4.02%+41.64%+42.38% 374B
-0.52%+2.72%+24.32%+41.06% 302B
-1.06%+4.76%+1.19%+12.65% 259B
+1.03%+5.83%+51.11%+72.96% 238B
-0.53%+2.34%-17.77%-53.66% 208B
+0.42%+5.63%+27.86%+92.24% 181B
-0.36%+4.09%+8.08%-22.65% 160B
Average -0.22%+4.81%+28.95%+45.83% 395.98B
Weighted average by Cap. -0.24%+4.94%+42.48%+69.13%

Financials

2026 *2027 *
Net sales 67.58B 57.92B 54.18B 49.54B 93.48B 6,471B 94.48B 641B 249B 3,250B 254B 248B 10,752B 73.52B 63.01B 58.94B 53.89B 102B 7,040B 103B 697B 271B 3,535B 276B 270B 11,696B
Net income 13.86B 11.88B 11.11B 10.16B 19.17B 1,327B 19.38B 132B 51.13B 666B 52.05B 50.92B 2,205B 18.91B 16.21B 15.16B 13.86B 26.16B 1,811B 26.44B 179B 69.77B 909B 71.02B 69.48B 3,009B
Net Debt 60.49B 51.84B 48.5B 44.34B 83.67B 5,792B 84.56B 574B 223B 2,908B 227B 222B 9,623B 51.66B 44.27B 41.42B 37.87B 71.46B 4,947B 72.22B 490B 191B 2,484B 194B 190B 8,218B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-08-24 $264.52 -0.17% 3,883,803
26-08-21 $264.96 +1.20% 5,157,192
26-08-20 $261.83 -1.56% 5,228,907
26-08-19 $265.97 +2.72% 5,535,972
26-08-18 $258.92 +3.43% 5,010,229
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
264.52USD
Average target price
276.59USD
Spread / Average Target
+4.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock